{"id":"W2022076442","doi":"10.3747/co.v16i0.415","title":"Adjuvant and Neoadjuvant Small-Molecule Targeted Therapy in High-Risk Renal Cell Carcinoma","year":2009,"lang":"en","type":"article","venue":"Current Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Temsirolimus; Medicine; Sorafenib; Oncology; Sunitinib; Adjuvant; Internal medicine; Renal cell carcinoma; Bevacizumab; Neoadjuvant therapy; Adjuvant therapy; Targeted therapy; Pazopanib; Cancer; Chemotherapy; Hepatocellular carcinoma; Breast cancer; PI3K/AKT/mTOR pathway","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001187711,0.0002718149,0.001202783,0.001164517,0.0001248341,0.0006299492,0.0003139728,0.0006822922,0.001268914],"category_scores_gemma":[0.002179227,0.0001433562,0.0006666626,0.001741832,0.0002029198,0.0005682297,0.0001463703,0.0003266708,0.0002021119],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005830569,"about_ca_system_score_gemma":0.001324493,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005896748,"about_ca_topic_score_gemma":0.001494844,"domain_scores_codex":[0.9995475,0.0001888193,0.0001243077,0.00003193277,0.00008978137,0.00001770465],"domain_scores_gemma":[0.9978911,0.001593084,0.0003371288,0.00001698823,0.0001282316,0.00003342255],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001362307,0.0002084325,0.005793128,0.2606687,0.001284991,0.00350697,0.0003489096,0.0006709963,0.006018206,0.0007748129,0.005694248,0.7136683],"study_design_scores_gemma":[0.002397784,0.007499937,0.08331055,0.2259597,0.02309941,0.07226649,0.001534906,0.001740496,0.0163301,0.004001573,0.5616817,0.0001773616],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.003944308,0.9950117,0.00007811246,0.0001745698,0.0000647091,0.0000169356,0.00002213372,0.000002013614,0.0006855092],"genre_scores_gemma":[0.04398346,0.9543719,0.0005551816,0.0003934271,0.000329641,0.00005664677,0.00006073441,0.000001788942,0.0002472743],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.001268914,"threshold_uncertainty_score":0.006281316,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0492257500895267,"score_gpt":0.3159595353086008,"score_spread":0.2667337852190741,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}